TechInvention partners Eubiologics to bring oral cholera vaccine to India

New Delhi: TechInvention Lifecare has tied up with South Korea-based biopharmaceutical firm Eubiologics Co Ltd for bringing in oral cholera vaccine 'Euvichol-Plus' to India. The vaccine is prequalified by the World Health Organization (WHO), TechInvention Lifecare Pvt Ltd said in a statement.

Eubiologics has so far supplied 55 million doses to UN healthcare agencies. Euvichol-Plus has been supplied to around 22 countries across the globe, it added.

"It is our endeavour to bring in a WHO prequalified oral cholera vaccine (OCV) in India for managing potential outbreak risk caused due to the often-neglected disease like cholera," TechInvention Founder and CEO Syed Ahmed said.

In a similar vein, Eubiologics Co CEO Yeong-Ok Baik said, "The collaboration between Eubiologics and Techinvention is aimed at reducing the disease burden and saving lives of Indian children by effective vaccination through our WHO-prequalified cholera vaccine, Euvichol-Plus in a unidose pack."